join us on facebook twitter
Search our site
Are You Sleeping by Kathleen Barber Read the opening extract of the brand new Kathleen Barber book before its publication on 27/12/2017

Emerging Drugs and Targets for Alzheimer's Disease Volume 1: Beta-Amyloid by Ana (Centro de Investigaciones Biologicas-CSIC, Spain) Martinez
  

Emerging Drugs and Targets for Alzheimer's Disease Volume 1: Beta-Amyloid

,

Part of the Drug Discovery Series

Synopsis

Emerging Drugs and Targets for Alzheimer's Disease Volume 1: Beta-Amyloid by Ana (Centro de Investigaciones Biologicas-CSIC, Spain) Martinez

Alzheimer's disease is the most prevalent neurodegenerative disorder in the elderly. A recent study from the Bloomberg School of Public Health recently estimated that over 26 million people were living with the disease in 2006 and that the global prevalence of the disease will grow to 106 million by 2050. By that time, 43 per cent of those living with the disease will need high-level care, equivalent to that of a nursing home. However, even if modest advances in preventing or delaying the disease's progression were made, it could have a huge impact on global public health. According to this study, interventions that could delay the onset of the disease by as little as one year would reduce the prevalence of the disease by 12 million fewer cases in 2050. These figures reinforce how important it is to find an effective intervention for Alzheimer's disease. Emerging Drugs and Targets for Alzheimer's Disease collects some of the most outstanding examples of new drugs currently under pharmaceutical development or new targets in the validation process that will reach the Alzheimer's drug market over the next few years as disease modifying drugs. Written by a team of distinguished experts, these volumes are an essential resource for scientists in the pharmaceutical and biotechnology industries and academics working in the neurosciences field.

About the Author

Ana Martinez obtained her PhD in Organic Chemistry from the Complutense University of Madrid before becoming a researcher at the Medicinal Chemistry Institute of the Spanish National Council for Research (CSIC). Since 1995, her interests have focused on neurodegenerative disorders and she has led numerous research projects on the medicinal chemistry and rational drug design with the aim of finding new treatments for Alzheimer's disease. In February 2002, she joined NeuroPharma (now NOSCIRA) as R&D Director where she led projects from the discovery of potential new therapies to the final proof of concept in animal models. In February 2008, she returned to her academic position at the Medicinal Chemistry Institute (CSIC) leading several projects on neurodegenerative disease therapies and acting as an external scientific advisor to a number of pharmaceutical companies. Her main areas of research currently involve GSK-3 inhibitors and dual binding site acetylcholinesterase inhibitors. She has authored over a hundred and fifty scientific publications and has more than twenty active patents in the field.

More books by this author
Author 'Like for Like' recommendations

Loading other formats...

Book Info

Publication date

1st May 2010

Author

Ana (Centro de Investigaciones Biologicas-CSIC, Spain) Martinez

More books by Ana (Centro de Investigaciones Biologicas-CSIC, Spain) Martinez
Author 'Like for Like'
    recommendations

Publisher

Royal Society of Chemistry

Format

Hardback
342 pages

Categories

Pharmacology
AlzheimerÍs & dementia

ISBN

9781849730631

Insightful reader reviews and unbiased recommendations. I don't know how I chose books before Lovereading! An essential for all book lovers.

Sarah Harper

You can trust Lovereading to show unbiased reviews by actual, ordinary readers that help likeminded booklovers choose their next great read.

Linda Hill

Lovereading is a wonderful way to expand my literary horizons, discover inspiring authors & get the chance to read new novels first. #loveit

Zarina de Ruiter

Lovereading does a stella job in promoting both new and established authors.

Iris Clements

Lovereading always comes up with great suggestions and has introduced me to enjoyable books and new authors to discover.

Gaynor Passmore

For me, to read is to learn, to reflect, to escape, to think, to contemplate and my time for space and calm.

Sally Ellsmore

The selections are so varied and the reader reviews are so helpful. A fantastic website for those who love books.

Ann Quintilla

It is a website dedicated to those who adore reading It really is a one stop shop for book lovers. Love it!

Edel Waugh

Lovereading4kids

Lovereading4schools